The largest database of trusted experimental protocols

Isa 206 vg adjuvant

Manufactured by Seppic
Sourced in France

ISA 206 VG is an adjuvant developed by Seppic. It is designed to enhance the immune response to vaccines. The core function of ISA 206 VG is to act as an immunostimulant.

Automatically generated - may contain errors

5 protocols using isa 206 vg adjuvant

1

FMD Vaccine Antigen Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To prepare the FMD vaccine antigen, two additives based on Tris-KCl buffer were added to the purified FMDV O Jincheon virus: (i) 3 mM calcium chloride and (ii) 10% sucrose with 5% lactalbumin hydrolysate (SLA). The vaccine antigen was mixed with 1% saponin (Sigma-Aldrich) and 10% aluminum hydroxide gel (General Chemical, Moorestown, NJ, USA), and then, ISA 206 VG adjuvant (Seppic, Paris, France) was added in a 1:1 ratio to make 2 mL/dose of the test vaccine. After mixing, it was incubated at 20 °C for 1 h in a water bath without light exposure and then stored at 4 °C until use.
+ Open protocol
+ Expand
2

Development of Foot-and-Mouth Disease Vaccine

Check if the same lab product or an alternative is used in the 5 most similar protocols
The purified FMDV Asia1/MOG/05-R antigen (15 μg per dose) derived from the 2 L bioreactor was mixed with 1% saponin (Sigma-Aldrich) and 10% aluminum hydroxide gel (General Chemical, Moorestown, NJ, USA) to prepare a monovalent vaccine. Next, the ISA 206 VG adjuvant (Seppic, Paris, France), pre-warmed at 30 °C, was added at a ratio of 1:1, resulting in a 2 mL/dose of experimental vaccine. The mixtures were incubated at 20 °C for 1 h in a water bath without light exposure and stored at 4 °C until use. Two-month-old pigs (n = 5) that had not been previously vaccinated against FMD were immunized twice at the four-week interval with the monovalent Asia1/MOG/05-R vaccine. The control group comprised three unvaccinated pigs. Blood samples were collected at 0, 14, 21, 28, 35, 42, 49, and 56 days post-vaccination. Animal experiments in this study were approved by the Institutional Animal Care and Use Committee (IACUC) of the Animal and Plant Quarantine Agency (IACUC No. 2023-761).
+ Open protocol
+ Expand
3

Preparation of FMD Vaccine Antigens

Check if the same lab product or an alternative is used in the 5 most similar protocols
FMD vaccines were prepared with (i) PEG-precipitated and (ii) chloroform-treated FMD vaccine antigens. The inactivated viral culture supernatant was obtained by the method described in Section 2.1, and the following procedures were performed. For the first group, the supernatant was treated with 7.5% (w/v) PEG 6000 (Sigma-Aldrich), stirred overnight at 4 °C, and centrifuged at 10,000× g for 30 min. After the supernatant was removed, the pellet was resuspended in tris–KCl buffer (pH 7.6) and adjusted to a concentration of 15 μg/mL. For the second group, the supernatant was mixed with 10% (v/v) chloroform by inverting for 5 min, and centrifuged at approximately 3000× g for 15 min. The aqueous layer on the top of the organic solvent layer was harvested and concentrated to a final concentration of 15 μg/mL by an ultrafiltration device fitted with a polyethersulfone membrane with a MWCO (molecular weight cutoff) of 300 kDa (Millipore, Billerica, MA, USA). Saponin (Sigma-Aldrich) and aluminum hydroxide gel (General Chemical, Parsippany, NJ, USA) were added to these two types of antigens, and then the ISA 206 VG adjuvant (Seppic, Paris, France) pre-warmed at 30 °C was added in a ratio of 1:1. After the mixtures were blocked from light and incubated at 20 °C for 1 h in a water bath, they were stored at 4 °C until use.
+ Open protocol
+ Expand
4

FMDV Vaccine Preparation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The experimental vaccines were prepared with the FMDV O/Boeun/SKR/2017 strain via: (i) PEG-precipitation; and (ii) heparin affinity chromatography. For the first group, the FMDV culture supernatant was treated with 7.5% (w/v) PEG 6000 (Sigma-Aldrich), stirred overnight at 4 °C, and centrifuged at 10,000× g for 30 min. After the supernatant was removed, the pellet was resuspended in Tris-KCl buffer (20 mM Tris-HCl, 300 mM KCl, pH 7.6) and adjusted to a concentration of 15 μg/mL. For the second group, the heparin column eluted antigens were concentrated to 15 μg/mL using a 10-kDa cutoff Centricon Plus-70 centrifugal unit (Merck Millipore). Saponin (Sigma-Aldrich) and aluminum hydroxide gel (General Chemical, Parsippany, NJ, USA) were added to these two kinds of antigens, and the ISA 206 VG adjuvant (Seppic, Paris, France) pre-warmed at 30 °C was then added in a ratio of 1:1. After the mixtures were incubated at 20 °C for 1 h in a water bath with blocked light, they were stored at 4 °C until use.
+ Open protocol
+ Expand
5

Bivalent FMDV Vaccine Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antigens for type O and A, as described in Section 2.7, were mixed with 1% saponin (Sigma-Aldrich) and 10% aluminum hydroxide gel (General Chemical, NJ, USA) to prepare a bivalent vaccine. The ISA 206 VG adjuvant (Seppic, Paris, France) pre-warmed at 30 °C was then added at a ratio of 1:1, resulting in 1 mL/dose or 2 mL/dose including 15 µg of the types O and A. After the mixtures were incubated at 20 °C for 1 h in a water bath without light exposure, they were stored at 4 °C until use. A total of 10 guinea pigs weighing 230–250 g was divided into two groups. Animals in the first group (n = 5) were inoculated intramuscularly at a volume of 1/10 of 1 mL/dose, and those in the other group (n =5) were inoculated intramuscularly at a volume of 1/10 of 2 mL/dose. Blood samples of each guinea pig were collected at 0, 7, 14, 21, 28, 56, and 84 days post-vaccination (dpv). VN titers with sera at 28 dpv were investigated against homologous and heterologous viruses using several topotypes of viruses. For serotype O viruses, O/Gimje/SKR/2016 and O/Jincheon/SKR/2014 belong to the SEA topotypes. The two ME-SA topotypes of the viruses were O/Anseong/SKR/2019 and O/VIT/2013. Cathay’s topotypes of the viruses were Taiwan 97. For serotype A viruses, the A/ Pocheon/SKR/2010, A/Gimpo/SKR/2018 (SEA-97), A22 Iraq (A22), and A/Nepal/12/2017 (G-VII) belong to Asia topotypes (Figure S1).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!